Business

JP Morgan Up Almost 3% In Pre-Market

JP Morgan's (JPM) results impressed. The stock is up to $51.52, or close to 3%, in pre-market trading, an indication that it could pass its 52-week high today.Net income at ...
Read Full Story »

Ahead of the Earnings: Merck Gaining Respectability Again?

We can see the sweat on their brow, but all in all Merck (MRK) is running a pretty good race these days going into Thursday’s earnings.  With the recent pop ...
Read Full Story »

Media Digest 4/18/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, DaimlerChrysler (DCX) intends to build two plants for its Chrysler division to manufacture more fuel-efficient cars. The cost of the plants will be about $3 billion.Reuters reports ...
Read Full Story »

Tuesday’s Top Biotech & Medical Stocks

by H.S. AyoubBioHealth Investor.com (more…) ...
Read Full Story »

Targacept: Late Day Volume Surge Deserves Attention

by H.S. AyoubBioHealth Investor.com (more…) ...
Read Full Story »

Cramer on the Superior Offshore IPO

Cramer probably just wrecked an IPO called Superior Offshore (Proposed Ticker is DEEP-NASDAQ) as a sleeper IPO that he thinks is mispriced that will come to market at the end ...
Read Full Story »

Cramer: Gannett Should Acquire Monster Worldwide (MNST)

Tonight on CNBC's Mad Money, Cramer's first message was for Gannett (GCI-NYSE): he said that they should go out and acquire Monster Worldwide (MNST-NASDAQ) to save the company.  It is ...
Read Full Story »

Cramer Notes Medical Stocks That Bottomed

On today's STOP TRADING segment on CNBC, Jim Cramer came out discussing ICD's in the medical device sector. Cramer said that St. Jude Medical (STJ-NYSE) would be an ideal buyout ...
Read Full Story »

Cervical Cancer Vaccine Wars Heating Up (GSK, MRK)

GlaxoSmithKline (GSK-NYSE/ADR) has just announced more positive data on its cervical cancer vaccine called CERVARIX(R).  The company has said that it demonstrated 100% protection against "HPV" (Human Papillomavirus-type 16 & ...
Read Full Story »

24/7 Wall St. Starbucks Store Evaluation Tour

Peter Lynch, who had one of the great investment track records while at Fidelity once made this point:  "An amateur investor can pick tomorrow's big winners by paying attention to ...
Read Full Story »

DirecTV And Echostar: The Crystal Ball Approach

The folks over at Cowen & Company have a novel theory about the future of satellite TV. The research operations has a "neutral" on Echostar (DISH) and DirecTV (DTV) with ...
Read Full Story »

Will Sirius Hold $3.00? Senate Hearings Today

There are two key levels that traders watch in lower priced stocks: $5.00 is the first and then $3.00 is the second.  Some become unable to short at levels under ...
Read Full Story »

Cell Genesys Showing New Positive Study Data

Cell Genesys, Inc. (CEGE-NASDAQ) is trading up more than 7% at $5.50 in earlybird trading on thin volume this morning on its new prostate cancer studies.  Yesterday it closed down ...
Read Full Story »

Coke: Overseas Sales Save The Quarter

Coke (KO) did better than expected in the last quarter. And, international sales saved the company's bacon. Earnings moved up to $1.26 billion for the Q from $1.11 billion the ...
Read Full Story »

Cable’s High Water Mark?

Over the last year, shares in Comcast (CMCSA) are up 50%. Charter Communications (CHTR) have risen over 200%. Time Warner has cashed in some of its cable chips by taking ...
Read Full Story »